Clinical trial
Treatment of Tardive Dyskinesia With Galantamine
NCT00164242 · Caroff, Stanley N., M.D., Other · Completed
Key facts
| NCT number | NCT00164242 |
|---|---|
| Title | Treatment of Tardive Dyskinesia With Galantamine |
| Official title | Treatment of Tardive Dyskinesia With Galantamine |
| Lead sponsor | Caroff, Stanley N., M.D., Other |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tardive Dyskinesia |
| Intervention type | Drug |
| Interventions | Galantamine |
| Enrollment | 36 |
| Start date | Jan 1, 2002 |
| Completion | Oct 1, 2004 |
| First posted | Sep 14, 2005 |
| Last update posted | Sep 14, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: